Trial drug Ibrutinib 'turns off' leukemia cells
Last Updated: 171 days ago
COLUMBUS, Ohio - An experimental pill has given leukemia patients hope for a cure.
Doctors the Wexner Medical Center at Ohio State University say leukemia patients who started taking Ibrutinib several years ago have all gone into remission.
Researchers say the drug is similar to a light switch – it turns power "off" to the cancer cells.
Trial patient Dennis Hickey said he was told 10 years ago that he had terminal cancer, but he's now the oldest living member of his family.
"I've lived longer than anyone else in my family. I have four brothers and they didn't live out of their 50s. Cancer runs in our family and I'm going to be 73 in July," Hickey said.
According to Dr. John Byrd, of the 900 patients in the trial, all have gone into remission.
Copyright 2013 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.